Goldman Sachs Group Inc Cytosorbents Corp Transaction History
Goldman Sachs Group Inc
- $613 Billion
- Q4 2024
A detailed history of Goldman Sachs Group Inc transactions in Cytosorbents Corp stock. As of the latest transaction made, Goldman Sachs Group Inc holds 25,143 shares of CTSO stock, worth $25,394. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,143Holding current value
$25,394% of portfolio
0.0%Shares
10 transactions
Others Institutions Holding CTSO
# of Institutions
57Shares Held
16.3MCall Options Held
15.4KPut Options Held
0-
Avenir Corp Washington, DC2.98MShares$3.01 Million0.45% of portfolio
-
Skylands Capital, LLC2.78MShares$2.81 Million0.38% of portfolio
-
Granahan Investment Management, LLC Waltham, MA2.09MShares$2.12 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.95MShares$1.97 Million0.0% of portfolio
-
Neuberger Berman Group LLC New York, NY1.78MShares$1.8 Million0.0% of portfolio
About Cytosorbents Corp
- Ticker CTSO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 43,577,400
- Market Cap $44M
- Description
- Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...